Saroja Pharma Indus Ind L Stock Price Today (NSE: SAROJA)
Fundamental Score
Saroja Pharma Indus Ind L Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Saroja Pharma Indus Ind L share price today is ₹30.00, up +0.00% on NSE/BSE as of 31 July 2026. Saroja Pharma Indus Ind L (SAROJA) is a Small-cap company in the Specialty Chemicals sector with a market capitalisation of ₹12.04 (Cr). The 52-week high for SAROJA share price is ₹60.00 and the 52-week low is ₹28.15. At a P/E ratio of 7.43x, SAROJA is currently trading below its industry average P/E of 31.95x. The company has a Return on Equity (ROE) of 9.83% and a debt-to-equity ratio of 0.83.
Saroja Pharma Indus Ind L Share Price Chart — NSE/BSE Historical Performance
Saroja Pharma Indus Ind L share price chart: -9.09% return over the past month. 52-week high ₹60.00, 52-week low ₹28.15.
Saroja Pharma Indus Ind L — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹30.00 | ₹30.00 | ₹29.85 | ₹30.00 | 6.40K (Cr) | |
| ₹29.95 | ₹29.95 | ₹29.95 | ₹29.95 | 6.40K (Cr) | |
| ₹33.00 | ₹33.00 | ₹33.00 | ₹33.00 | 1.60K (Cr) | |
| ₹32.50 | ₹32.50 | ₹32.00 | ₹32.50 | 4.80K (Cr) | |
| ₹32.50 | ₹32.50 | ₹32.50 | ₹32.50 | 1.60K (Cr) | |
| ₹33.00 | ₹33.00 | ₹33.00 | ₹33.00 | 1.60K (Cr) | |
| ₹32.85 | ₹32.85 | ₹32.85 | ₹32.85 | 3.20K (Cr) | |
| ₹29.40 | ₹29.40 | ₹29.40 | ₹29.40 | 6.40K (Cr) | |
| ₹29.35 | ₹29.35 | ₹29.35 | ₹29.35 | 1.60K (Cr) | |
| ₹28.15 | ₹28.15 | ₹28.15 | ₹28.15 | 3.20K (Cr) |
Saroja Pharma Indus Ind L — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹33.00 | ₹33.00 | ₹29.85 | ₹30.00 | -9.09% | |
| ₹32.50 | ₹32.50 | ₹32.00 | ₹32.50 | +0.00% | |
| ₹32.50 | ₹32.50 | ₹32.50 | ₹32.50 | +0.00% | |
| ₹29.40 | ₹33.00 | ₹29.40 | ₹33.00 | +12.24% | |
| ₹28.15 | ₹29.35 | ₹28.15 | ₹29.35 | +4.26% | |
| ₹35.80 | ₹36.05 | ₹35.00 | ₹35.00 | -2.23% | |
| ₹39.20 | ₹39.55 | ₹32.50 | ₹32.50 | -17.09% | |
| ₹42.00 | ₹43.05 | ₹39.20 | ₹40.00 | -4.76% | |
| ₹41.25 | ₹42.00 | ₹39.50 | ₹42.00 | +1.82% | |
| ₹45.00 | ₹48.00 | ₹40.70 | ₹42.70 | -5.11% | |
| ₹48.10 | ₹51.75 | ₹43.70 | ₹45.00 | -6.44% | |
| ₹35.80 | ₹60.00 | ₹35.80 | ₹47.85 | +33.66% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Saroja Pharma Indus Ind L Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Saroja Pharma Indus Ind L Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SAROJA across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Attractive Valuation (P/E: 7.43 vs Industry: 31.95)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (48.57%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Consistent Growth Track Record (13.89% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Strong Profit Growth Track Record (17.28% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Balanced Promoter Holding (73.02%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
5 factors identified
Below-Average Return on Equity (9.83%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Revenue Contraction (-10.37%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Weak Earnings Growth (-64.65% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
Negative Free Cash Flow (₹-14.73 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Saroja Pharma Indus Ind L vs Specialty Chemicals Peers
Peer Comparison - Specialty Chemicals
Compare Saroja Pharma Indus Ind L with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
45.3/100 | ₹30.00₹30 | ₹12.04₹12.04 | 7.43Average 7.4 Average | 9.83%Poor 9.83% Poor | 13.02%Average 13.02% Average | 0.83Good 0.8 Good | 17.28%Excellent 17.28% Excellent | 13.89%Good 13.89% Good | 0.00% | |
Pidilite Industries LimitedPidilite Indust... PIDILITIND • 500331 | 65.3/100 | ₹1611.40₹1611 | ₹159989.82₹159989.82 | 64.97Average 65.0 Average | 23.92%Excellent 23.92% Excellent | 31.02%Excellent 31.02% Excellent | 0.04Excellent 0.0 Excellent | 16.69%Excellent 16.69% Excellent | 14.89%Good 14.89% Good | 0.73% |
Gujarat Fluorochemicals LtdGujarat Fluoroc... FLUOROCHEM • 542812 | 42.9/100 | ₹4366.80₹4367 | ₹45440.05₹45440.05 | 77.27Average 77.3 Average | 7.78%Poor 7.78% Poor | 9.86%Poor 9.86% Poor | 0.29Excellent 0.3 Excellent | 36.34%Excellent 36.34% Excellent | 13.52%Good 13.52% Good | 0.07% |
Navin Fluorine International LtdNavin Fluorine ... NAVINFLUOR • 532504 | 62.7/100 | ₹7567.50₹7568 | ₹39027.62₹39027.62 | 58.37Average 58.4 Average | 20.26%Excellent 20.26% Excellent | 21.37%Excellent 21.37% Excellent | 0.32Excellent 0.3 Excellent | 22.16%Excellent 22.16% Excellent | 22.95%Excellent 22.95% Excellent | 0.20% |
Deepak Nitrite LtdDeepak Nitrite ... DEEPAKNTR • 506401 | 32.8/100 | ₹1662.20₹1662 | ₹23159.08₹23159.08 | 41.37Average 41.4 Average | 9.97%Poor 9.97% Poor | 11.49%Average 11.49% Average | 0.28Excellent 0.3 Excellent | -6.33%Poor -6.33% Poor | 12.59%Good 12.59% Good | 0.44% |
Aether Industries LtdAether Industri... AETHER • 543534 | 36.3/100 | ₹1539.60₹1540 | ₹19624.13₹19624.13 | 86.74Average 86.7 Average | 9.66%Poor 9.66% Poor | 11.92%Average 11.92% Average | 0.19Excellent 0.2 Excellent | — — | — — | 0.00% |
Aarti Industries LtdAarti Industrie... AARTIIND • 524208 | 38.7/100 | ₹489.10₹489 | ₹18171.13₹18171.13 | 44.10Average 44.1 Average | 7.13%Poor 7.13% Poor | 6.85%Poor 6.85% Poor | 0.83Good 0.8 Good | -4.67%Poor -4.67% Poor | 12.96%Good 12.96% Good | 0.20% |
Atul LtdAtul Ltd... ATUL • 500027 | 58.2/100 | ₹6736.50₹6737 | ₹18051.49₹18051.49 | 26.58Average 26.6 Average | 11.49%Average 11.49% Average | 14.90%Average 14.90% Average | 0.03Excellent 0.0 Excellent | 1.26%Average 1.26% Average | 10.95%Good 10.95% Good | 0.49% |
BASF India LtdBASF India Ltd... BASF • 500042 | 52.2/100 | ₹3633.80₹3634 | ₹16002.35₹16002.35 | 38.38Average 38.4 Average | 10.92%Average 10.92% Average | 14.68%Average 14.68% Average | 0.03Excellent 0.0 Excellent | 7.67%Good 7.67% Good | 9.41%Good 9.41% Good | 0.68% |
Fine Organic Industries LtdFine Organic In... FINEORG • 541557 | 62.09999999999999/100 | ₹4816.50₹4817 | ₹15713.17₹15713.17 | 38.15Average 38.1 Average | 16.61%Good 16.61% Good | 21.47%Excellent 21.47% Excellent | 0.03Excellent 0.0 Excellent | 27.91%Excellent 27.91% Excellent | 15.86%Excellent 15.86% Excellent | 0.21% |
Anupam Rasayan India LtdAnupam Rasayan ... ANURAS • 543275 | 33.3/100 | ₹1207.80₹1208 | ₹14449.70₹14449.70 | 84.94Average 84.9 Average | 5.50%Poor 5.50% Poor | 7.36%Poor 7.36% Poor | 0.56Good 0.6 Good | 19.29%Excellent 19.29% Excellent | 23.88%Excellent 23.88% Excellent | 0.06% |
Top Specialty Chemicals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Pidilite Industries Limited share price159989.82 Cr
- Gujarat Fluorochemicals Ltd share price45440.05 Cr
- Navin Fluorine International Ltd share price39027.62 Cr
- Deepak Nitrite Ltd share price23159.08 Cr
- Aether Industries Ltd share price19624.13 Cr
Saroja Pharma Indus Ind L PE Ratio History
Historical price-to-earnings ratio for SAROJA — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2023 | ₹2.64 | ₹53.00 | 20.1x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Saroja Pharma Indus Ind L Quarterly Performance
Latest quarterly metrics for SAROJA — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-10.37%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
48.57%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
13.89%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
17.28%
Compounded annual net profit growth over 5 years
Saroja Pharma Indus Ind L Technical Indicators
SMA 50, SMA 200, RSI and volume signals for SAROJA — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Saroja Pharma Indus Ind L Financial Statements
Annual income statement, balance sheet and cash flow for Saroja Pharma Indus Ind L (SAROJA) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Saroja Pharma Indus Ind L
About SAROJA (Saroja Pharma Indus Ind L)
Saroja Pharma Indus Ind L (SAROJA) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Specialty Chemicals sector w...ith a current market capitalisation of ₹12.04 (Cr). Saroja Pharma Indus Ind L has delivered a Return on Equity (ROE) of 9.83% and a ROCE of 13.02%. The debt-to-equity ratio stands at 0.83, reflecting the company's capital structure. Investors tracking SAROJA share price can monitor key metrics including P/E ratio, promoter holding of 73.02%, and quarterly earnings growth.
Company Details
SAROJA Share Price: Frequently Asked Questions
What is the current share price of Saroja Pharma Indus Ind L?
Saroja Pharma Indus Ind L (SAROJA) trades at ₹30.00 on NSE. Market cap ₹12.04 (Cr). Educational data only.
What is the P/E ratio of Saroja Pharma Indus Ind L?
Saroja Pharma Indus Ind L has a P/E of 7.43x vs industry average 31.95x.
What is the Bull Run score for Saroja Pharma Indus Ind L?
Saroja Pharma Indus Ind L has a Bull Run score of 45.3/100 based on 25+ financial parameters.
Does Saroja Pharma Indus Ind L pay dividends?
Saroja Pharma Indus Ind L has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Saroja Pharma Indus Ind L?
Saroja Pharma Indus Ind L has ROE of 9.83%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Saroja Pharma Indus Ind L?
Saroja Pharma Indus Ind L has debt-to-equity of 0.83.
Is Saroja Pharma Indus Ind L a good investment?
Bull Run gives Saroja Pharma Indus Ind L a score of 45.3/100. This is not investment advice — consult a SEBI-registered advisor.